Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL* protocol

• Main Authors: Teodoro Iturbe-Hernandez (Author), Luis García de Guadiana Romualdo (Author), Ignacio Gil Ortega (Author), Antonio Martínez Francés (Author), Olga Meca Birlanga (Author), Juan José Cerezo-Manchado (Author)
• Format: Knjiga
• Izdano: BioExcel Publishing Ltd, 2020-09-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Atrial fibrillation is a frequent complication among patients with severe coronavirus disease-2019 (COVID-19) infection. Both direct and indirect mechanisms through COVID-19 have been described to explain this relationship. COVID-19 infection increases the risk of developing both arterial and venous...